Actualités Novartis Ag Basel Namen Akt (PK) - NVSEF | Actions OTCMarkets | ADVFN

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Novartis Ag Basel Namen Akt (PK) (NVSEF)
Novartis Ag Basel Namen Akt (PK) (NVSEF) Actualités

Novartis Ag Basel Namen Akt (PK) (NVSEF)

109,00

0,00

(0,00%)

Fermé 16 Mars 9:00PM

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Form SD - Specialized disclosure report

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Novartis Ag Basel Namen ... (PK)

Lyxor STOXX Europe 600 I...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales